EMMAUS LIFE SCIENCES INC NEW News

Great Elm Group And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inte

BenzingaMar 1 19:56

EMMAUS LIFE SCIENCES INC NEW(EMMA.US) Officer Buys US$14,694 in Common Stocks

$EMMAUS LIFE SCIENCES INC NEW(EMMA.US)$ Officer LEE WILLIS C purchased 115.2K shares of Common Stocks on Feb 26, 27, 28, 29, 2024 at an average price of $0.13 for a total value of $14,694.Source: Anno

Futu NewsMar 1 07:53

Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico

TORRANCE, Calif., Feb. 2, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease (SCD) treatment, today announced that it has received marketing authorization f

EMMAUS LIFE SCIENCES INC NEWFeb 2 13:00

(SEC Amendment) EMMAUS LIFE SCIENCES INC NEW(EMMA.US) Officer Buys US$15,285 in Common Stocks

$EMMAUS LIFE SCIENCES INC NEW(EMMA.US)$ Officer LEE WILLIS C purchased 121K shares of Common Stocks on Aug 25, 31, Nov 14, 28, 29, 30, 2023 at an average price of $0.13 for a total value of $15,285.So

Futu NewsJan 4 06:14

EMMAUS LIFE SCIENCES INC NEW(EMMA.US) Director Buys US$30,916 in Common Stocks

$EMMAUS LIFE SCIENCES INC NEW(EMMA.US)$ Director Lim Seah H. purchased 139.2K shares of Common Stocks on Oct 9, 2022 and Aug 25, 30, Sep 5, 2023 at an average price of $0.22 for a total value of $30,9

Futu NewsDec 20, 2023 09:22

EMMAUS LIFE SCIENCES INC NEW(EMMA.US) Officer Buys US$2,022.93 in Common Stocks

$EMMAUS LIFE SCIENCES INC NEW(EMMA.US)$ Officer LEE WILLIS C purchased 15,609 shares of Common Stocks on Aug 25, 31, Nov 14, 28, 29, 30, 2023 at an average price of $0.13 for a total value of $2,022.9

Futu NewsDec 5, 2023 10:11

Emmaus Life Sciences GAAP EPS of -$0.01, Revenue of $5M

Seeking AlphaNov 14, 2023 23:04

Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q3 Revenue $5M

09:33 AM EST, 11/14/2023 (MT Newswires) -- Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q3 Revenue $5M

MT NewswiresNov 14, 2023 22:33

Press Release: Emmaus Life Sciences Reports Q3 2023 Financial Results

Emmaus Life Sciences Reports Q3 2023 Financial Results PR Newswire TORRANCE, Calif., Nov. 14, 2023 TORRANCE, Calif., Nov. 14, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commer

Dow JonesNov 14, 2023 22:30

Emmaus Life Sciences Reports Q3 2023 Financial Results

TORRANCE, Calif., Nov. 14, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reporte

EMMAUS LIFE SCIENCES INC NEWNov 14, 2023 13:00

Emmaus Life Sciences Names Willis Lee, George Sekulich Interim Co-Presidents >EMMA

Emmaus Life Sciences Names Willis Lee, George Sekulich Interim Co-Presidents >EMMA

Dow JonesAug 23, 2023 21:06

Emmaus Life Sciences: Yutaka Niihara Will No Longer Serve as Chairman, CEO >EMMA

Emmaus Life Sciences: Yutaka Niihara Will No Longer Serve as Chairman, CEO >EMMA

Dow JonesAug 23, 2023 21:04

Press Release: Emmaus Life Sciences Reports Management Changes

Emmaus Life Sciences Reports Management Changes PR Newswire TORRANCE, Calif., Aug. 23, 2023 Principal Inventor of Endari(R) (L-glutamine oral powder) and Long-time Chairman and Chief Executive Offi

Dow JonesAug 23, 2023 21:00

Emmaus Life Sciences Reports Management Changes

Principal Inventor of Endari (L-glutamine oral powder) and Long-time Chairman and Chief Executive Officer Free to Purse New ProjectsCompany Appoints Interim Co-Presidents to Focus on Core BusinessTORR

EMMAUS LIFE SCIENCES INC NEWAug 23, 2023 12:00

Emmaus Life Sciences GAAP EPS of -$0.03, Revenue of $10.8M

Seeking AlphaAug 15, 2023 05:28

Press Release: Emmaus Life Sciences Reports Q2 2023 Financial Results

Emmaus Life Sciences Reports Q2 2023 Financial Results PR Newswire TORRANCE, Calif., Aug. 14, 2023 Record Net Revenues Contributed to Income from Operations Sixth Straight Quarterly Increase in Ne

Dow JonesAug 15, 2023 03:54

Emmaus Life Sciences Reports Q2 2023 Financial Results

Record Net Revenues Contributed to Income from OperationsSixth Straight Quarterly Increase in Net RevenuesTorrance CA, August 14, 2023 - Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage bi

EMMAUS LIFE SCIENCES INC NEWAug 14, 2023 12:00

The chief operating officer of EMMAUS LIFE SCIENCES INC NEW (EMMA.US) increased his common stock holdings by 29,500 shares, worth approximately $8,533

On June 3, it was reported that according to documents disclosed by the US Securities and Exchange Commission (SEC) on June 2, $EMMAUS LIFE SCIENCES INC NEW (EMMA.US) $ COO LEE WILLIS C increased its holdings of 29,500 common shares at an average price of $0.29 per share on 2022/9/20 and 2023/5/31, worth about 8,533 US dollars. Image source: SEC's official website What is a shareholding change statement? The SEC requires insiders of listed companies to publicly disclose their securities transactions and shareholding.

Futu NewsJun 3, 2023 02:10

Emmaus Life Sciences Receives Endari Marketing Authorization From the Bahrain NHRA

TORRANCE, Calif., May 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration Certificate (DRN-10164/23)

PR NewswireJun 1, 2023 02:11

Emmaus Life Sciences GAAP EPS of -$0.07, Revenue of $6.8M Beats by $1.8M

Seeking AlphaMay 16, 2023 16:11